Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Comerica Inc. buy JPMorgan Chase & Co.

Start price
€32.60
05.05.23 / 50%
Target price
€41.90
05.05.24
Performance (%)
52.82%
Price
€47.20
30.04.24
This prediction will end soon
Summary
This prediction is currently active. With a performance of 52.82% the BUY prediction by JPMorgan_Chase___Co_ is a big success. A total of €2.62 was paid as dividends for this prediction. This prediction currently runs until 05.05.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction

Comerica Incorporated (Symbol: CMA) is a leading financial services company based in Dallas, Texas, with a rich history dating back to its founding in Detroit, Michigan in 1849. Primarily operating within the banking sector, Comerica provides a diverse range of financial products and services, including personal and business banking, wealth management, and investment services. With a strong presence across the United States, Comerica caters to the needs of customers from various segments, such as small to mid-sized businesses, large corporations, and individual consumers. As a publicly traded company listed on the New York Stock Exchange, Comerica is committed to delivering shareholder value through continued growth, innovation, and prudent risk management.

Performance without dividends (%)
Name 1w 1m
Comerica Inc. -4.065% -4.065%
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Comerica Inc. diskutieren
Prediction Buy
Perf. (%) 52.82%
Target price 41.897
Change
Ends at 05.05.24

Comerica Incorporated (NYSE: CMA) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $46.00 price target on the stock.
Ratings data for CMA provided by MarketBeat